Author:
Curtis Jeffrey R.,McInnes Iain B.,Rahman Proton,Gladman Dafna D.,Peterson Steven,Agarwal Prasheen,Yang Feifei,Kollmeier Alexa P.,Hsia Elizabeth C.,Shiff Natalie J.,Zhou Bei,Han Chenglong,Shawi May,Tillett William,Mease Philip J.
Funder
Janssen Global Services LLC
Janssen Research and Development
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference38 articles.
1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957–70.
2. Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology. 2012; 51:275–83.
3. Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharm Ther. 2010;35:680–9.
4. Bojke L, Spackman E, Hinde S, Helliwell P. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology (Oxford). 2012;51:210–5.
5. Kawalec P, Malinowski KP. The indirect costs of psoriatic arthritis: systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15:125–32.